A novel intronic circular RNA circFGFR1


Journal

Journal of translational medicine
ISSN: 1479-5876
Titre abrégé: J Transl Med
Pays: England
ID NLM: 101190741

Informations de publication

Date de publication:
22 Nov 2023
Historique:
received: 25 08 2023
accepted: 10 11 2023
medline: 24 11 2023
pubmed: 23 11 2023
entrez: 23 11 2023
Statut: epublish

Résumé

Fibroblast growth factor receptor 1 (FGFR1) is a core component of the FGFs/FGFR pathway that activates multiple signalling pathways, including ERK1/2, PI3K/AKT, PLCγ, and NF-κB. Aberrant expression of FGFR1 due to gene amplification, chromosome rearrangement, point mutation, and epigenetic deregulations, have been reported in various cancers. FGFR1 overexpression has also been reported in prostate cancer (PCa), but the underlining mechanisms are not clear. Here we report a novel circular RNA, circFGFR1

Identifiants

pubmed: 37993879
doi: 10.1186/s12967-023-04718-y
pii: 10.1186/s12967-023-04718-y
pmc: PMC10664560
doi:

Substances chimiques

Receptor, Fibroblast Growth Factor, Type 1 EC 2.7.10.1
RNA, Circular 0
Phosphatidylinositol 3-Kinases EC 2.7.1.-
MicroRNAs 0
FGFR1 protein, human EC 2.7.10.1
FUS protein, human 0
RNA-Binding Protein FUS 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

840

Subventions

Organisme : National Natural Science Foundation of China
ID : 82273073
Organisme : National Natural Science Foundation of China
ID : 82273047
Organisme : National Natural Science Foundation of China
ID : 81872108
Organisme : National Natural Science Foundation of China
ID : 81872107
Organisme : National Natural Science Foundation of China
ID : 82203315
Organisme : National Natural Science Foundation of China
ID : 82203280

Informations de copyright

© 2023. The Author(s).

Références

Nat Commun. 2019 Sep 11;10(1):4119
pubmed: 31511520
Med Res Rev. 2014 Mar;34(2):280-300
pubmed: 23696246
Oncotarget. 2015 May 20;6(14):11994-2008
pubmed: 25596738
Front Med (Lausanne). 2022 May 06;9:861960
pubmed: 35602517
Cancer Res. 2014 Jan 15;74(2):609-20
pubmed: 24305876
Mol Cell. 2017 Jan 5;65(1):154-167
pubmed: 28041912
Cell Rep. 2015 Jan 13;10(2):170-7
pubmed: 25558066
Trends Immunol. 2022 Sep;43(9):757-775
pubmed: 35965153
Nat Struct Mol Biol. 2015 Mar;22(3):256-64
pubmed: 25664725
Genes Dev. 2012 Dec 15;26(24):2690-5
pubmed: 23249733
Mol Ther Nucleic Acids. 2019 Mar 1;14:609-616
pubmed: 30785065
Mol Cancer. 2019 Dec 9;18(1):179
pubmed: 31815619
Pharmacol Ther. 2021 Apr;220:107715
pubmed: 33141028
Cancer Cell. 2023 Jul 10;41(7):1309-1326.e10
pubmed: 37295428
Elife. 2019 Feb 05;8:
pubmed: 30720426
J Oral Pathol Med. 2018 Oct;47(9):816-822
pubmed: 30080932
Nature. 2021 Oct;598(7880):348-352
pubmed: 34552244
Nat Commun. 2021 Aug 13;12(1):4908
pubmed: 34389711
Cancer Lett. 2022 Apr 1;530:68-84
pubmed: 35051534
Pharmacol Res. 2020 Jan;151:104567
pubmed: 31770593
Gene. 2009 Jun 1;438(1-2):49-56
pubmed: 19303924
Ann Endocrinol (Paris). 2020 Feb;81(1):18-27
pubmed: 32127169
Environ Toxicol. 2022 Dec;37(12):2832-2843
pubmed: 36029209
Gene. 2007 Oct 1;400(1-2):150-7
pubmed: 17628354
Acta Neuropathol Commun. 2020 Feb 21;8(1):21
pubmed: 32085805
Physiol Rev. 2021 Apr 1;101(2):569-610
pubmed: 32730114
Lancet. 2021 Sep 18;398(10305):1075-1090
pubmed: 34370973
J Biol Chem. 2014 Jan 3;289(1):326-34
pubmed: 24257758
J Neurooncol. 2021 Dec;155(3):225-234
pubmed: 34796414
JCI Insight. 2018 Jul 26;3(14):
pubmed: 30046001
Clin Epigenetics. 2021 Dec 21;13(1):228
pubmed: 34933671
Nat Commun. 2017 Mar 30;8:14741
pubmed: 28358055
Biochim Biophys Acta Rev Cancer. 2021 Dec;1876(2):188595
pubmed: 34303787
Trends Cell Biol. 2015 Apr;25(4):221-33
pubmed: 25467007
Cell. 2019 Feb 7;176(4):831-843.e22
pubmed: 30735634
J Biol Chem. 2002 Mar 15;277(11):9278-85
pubmed: 11756440
J Biol Chem. 2013 May 10;288(19):13876-84
pubmed: 23569208
Cancer Sci. 2022 Feb;113(2):540-552
pubmed: 34897892
Sci Transl Med. 2014 Sep 3;6(252):252ra122
pubmed: 25186177
Nat Rev Dis Primers. 2017 Jul 13;3:17044
pubmed: 28703220
Cell. 2015 Mar 12;160(6):1125-34
pubmed: 25768908
Neurosci Lett. 2019 Aug 24;708:134176
pubmed: 31173847
Cell Death Differ. 2019 Jul;26(7):1346-1364
pubmed: 30341421
Cancer Lett. 2022 Jan 1;524:57-69
pubmed: 34656688
PLoS Med. 2019 Jul 2;16(7):e1002847
pubmed: 31265453
Exp Cell Res. 2010 Jan 15;316(2):194-202
pubmed: 19699737
Endocrinology. 2007 Dec;148(12):5966-76
pubmed: 17761769
J Mol Cell Cardiol. 2008 Mar;44(3):510-9
pubmed: 18275970
Oncogene. 2011 Oct 13;30(41):4231-42
pubmed: 21532615
J Vasc Res. 2012;49(3):249-59
pubmed: 22433836
Cancer Lett. 2018 Jun 1;423:36-46
pubmed: 29452146
Acta Neuropathol Commun. 2020 Aug 28;8(1):151
pubmed: 32859279
Nucleic Acids Res. 2020 Apr 17;48(7):3789-3805
pubmed: 31980816
Mol Cell. 2021 Oct 21;81(20):4300-4318.e13
pubmed: 34437836
J Biol Chem. 2005 Jun 3;280(22):21284-94
pubmed: 15811856
Nat Commun. 2023 Jul 25;14(1):4467
pubmed: 37491377
mBio. 2021 Aug 31;12(4):e0101721
pubmed: 34281396
J Helminthol. 2021 Jan 14;95:e1
pubmed: 33441208
Genome Biol. 2014 Jul 29;15(7):409
pubmed: 25070500
Eur J Cancer. 2021 Jul;151:136-149
pubmed: 33984662
Genome Med. 2018 May 23;10(1):37
pubmed: 29792227
Mol Biol Cell. 2010 Aug 1;21(15):2780-7
pubmed: 20554758
Wiley Interdiscip Rev RNA. 2016 May;7(3):330-40
pubmed: 26822113
Mol Cancer Res. 2017 Oct;15(10):1341-1353
pubmed: 28684636
Nature. 2013 Mar 21;495(7441):384-8
pubmed: 23446346
Curr Opin Struct Biol. 2019 Dec;59:134-142
pubmed: 31479821
Nat Cell Biol. 2021 Mar;23(3):278-291
pubmed: 33664496
J Exp Clin Cancer Res. 2020 Mar 17;39(1):51
pubmed: 32183847
Nat Commun. 2020 Nov 5;11(1):5611
pubmed: 33154349
Nat Rev Cancer. 2010 Feb;10(2):116-29
pubmed: 20094046
Eur Urol Oncol. 2022 Apr;5(2):164-175
pubmed: 34774481
J Biol Chem. 2001 Apr 20;276(16):13395-401
pubmed: 11278855
Cell Rep. 2020 May 12;31(6):107641
pubmed: 32402287
Clin Cancer Res. 2016 Jan 1;22(1):259-67
pubmed: 26373574
J Vis Exp. 2012 Mar 25;(61):
pubmed: 22472705
Cell Death Dis. 2019 Oct 17;10(11):792
pubmed: 31624242
Cancer Sci. 2023 Apr;114(4):1378-1395
pubmed: 36519785
Cancer Res. 2023 Sep 15;83(18):3077-3094
pubmed: 37363990
Cancer Discov. 2023 Jul 7;13(7):1592-1615
pubmed: 37011011
Nat Rev Urol. 2014 Nov;11(11):604
pubmed: 25245247
Nat Rev Clin Oncol. 2022 Mar;19(3):188-206
pubmed: 34912049
J Exp Clin Cancer Res. 2018 Jul 18;37(1):160
pubmed: 30021600
Pancreas. 2022 Sep 1;51(8):930-942
pubmed: 36607937
J Mol Biol. 2016 Jun 19;428(12):2652-2659
pubmed: 26920110
J Mol Med (Berl). 2013 Dec;91(12):1343-54
pubmed: 23974990
Genes Dev. 2016 Apr 1;30(7):751-71
pubmed: 27036966
Nat Genet. 2012 Dec;44(12):1302-9
pubmed: 23104007

Auteurs

Ruyue Wang (R)

Department of Pathology, West China Hospital, Sichuan University, Chengdu, 610041, China.

Jinjing Zhong (J)

Department of Pathology, West China Hospital, Sichuan University, Chengdu, 610041, China.

Xiuyi Pan (X)

Department of Pathology, West China Hospital, Sichuan University, Chengdu, 610041, China.

Zhengzheng Su (Z)

Department of Pathology, West China Hospital, Sichuan University, Chengdu, 610041, China.

Yunyi Xu (Y)

Department of Pathology, West China Hospital, Sichuan University, Chengdu, 610041, China.

Mengni Zhang (M)

Department of Pathology, West China Hospital, Sichuan University, Chengdu, 610041, China.

Xueqin Chen (X)

Department of Pathology, West China Hospital, Sichuan University, Chengdu, 610041, China.

Ni Chen (N)

Department of Pathology, West China Hospital, Sichuan University, Chengdu, 610041, China.

Ting Yu (T)

Department of Pathology, West China Hospital, Sichuan University, Chengdu, 610041, China. yuting_hx@scu.edu.cn.

Qiao Zhou (Q)

Department of Pathology, West China Hospital, Sichuan University, Chengdu, 610041, China. zhouqiao@scu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH